Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Neumora Therapeutics
company
Funding Round
Series B
Money Raised
$ 112M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Mubadala Capital Ventures | - | Yes | - | Detail |
| ARCH Venture Partners | - | - | - | Detail |
| Abu Dhabi Growth Fund | - | - | - | Detail |
| Altitude Life Science Ventures | - | - | - | Detail |
| Amgen | - | - | - | Detail |
| EXOR N.V. | - | - | - | Detail |
| F-Prime Capital | - | - | - | Detail |
| Invus | - | - | - | Detail |
| Newpath Management | - | - | - | Detail |
| Polaris Partners | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Oct 7, 2021 | Series A | $ 400M | ARCH Venture Partners,Alexandria Venture Investments,etc. | Detail |
| Oct 7, 2021 | Corporate Round | $ 100M | Amgen | Detail |
